Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Provides superior performance for the diagnosis of mononucleosis. One-step antibody test for IM that uses direct solid-phase immunoassay technology to detect IM heterophile antibodies in human serum, plasma, or whole blood.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
Isothermal Reverse Transcriptase-Helicase-Dependent Amplification (RT-HDA) assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal & nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider.
Achieve accurate, standardized results with best-in-class Influenza A performance with the Acucy™ Influenza A and B Test Kit and the Acucy™ Reader System.
OSOM™ Ultra Flu A and B is a rapid qualitative test that detects influenza type A and type B antigens directly from nasal swab, nasopharyngeal swab and nasal aspirate/wash specimens.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
SARS-CoV-2 Process Control can be used for SARS-CoV-2 assay development, full process control (including extraction), sample adequacy control and spike-in controls.
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
The Inactivated SARS-CoV-2 B.1.1.7 Whole Virus (Alpha Variant) can be used to monitor the extraction, amplification, and detection of SARS-CoV-2 molecular applications. Routine use of external quality controls monitor day to day performance of molecular testing procedures.
A rapid test based on lateral flow immunoassay intended for the qualitative detection of SARS-CoV¬2 in human nasopharyngeal swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare provider.
Rapid, qualitative detection of respiratory syncytial virus fusion protein in nasopharyngeal swabs or nasal aspirate specimens in children less than 6 years and adults over 60. Intended as an aid in the rapid laboratory diagnosis of acute respiratory syncytial virus infection in patients with such symptoms.
Lateral flow immunochromatographic assay intended for in-vitro rapid, simultaneous qualitative detection and differentiation of influenza A and B nucleoprotein antigens and SARS CoV-2 nucleocapsid antigen.